William G. Kaelin Jr.(1957)

Medicine

William G. Kaelin Jr. is a recipient of the Nobel Prize in Physiology or Medicine (2019) from United States. They have received 3 major awards in total. Their primary field is Medicine. They were educated at Duke University. They have been affiliated with Dana–Farber Cancer Institute.

United States
3
Major Awards
N/A
Publications
N/A
Citations
N/A
h-index
N/A
i10-index
N/A
Avg Citations/Paper

Career History

Sidney Farber Professor of Medicine

Dana-Farber Cancer Institute

Boston, US

2002 — Present

Principal Investigator

Howard Hughes Medical Institute

Chevy Chase, US

1998 — Present

Education

Duke University School of Medicine

M.D.

1982

Duke University

A.B.

1979

Duke University

B.A.

1979

Research Funding

Exploiting Protein Degraders, Endogenous Retrovirus Expression, and Synthetic Lethality in Breast Cancer

The Breast Cancer Research Foundation Inc.

2024 — 2025

Endogenous Retroviruses as Emerging Targets for Cancer Vaccines

American Cancer Society

2026 — 2028

Exploiting Protein Degraders, Endogenous Retrovirus Expression, and Synthetic Lethality in Breast Cancer

The Breast Cancer Research Foundation Inc.

2022 — 2023

Exploiting Protein Degraders, Endogenous Retrovirus Expression, and Synthetic Lethality in Breast Cancer

The Breast Cancer Research Foundation Inc.

2021 — 2022

2-Oxoglutarate Dependent Dioxygenases as Therapeutic Targets in Breast Cancers

The Breast Cancer Research Foundation Inc.

2017 — 2018

2-Oxoglutarate Dependent Dioxygenases as Therapeutic Targets in Breast Cancer

The Breast Cancer Research Foundation Inc.

2020 — 2021

Exploiting Protein Degraders, Endogenous Retrovirus Expression, and Synthetic Lethality in Breast Cancer

The Breast Cancer Research Foundation Inc.

2023 — 2024

2-Oxoglutarate Dependent Dioxygenases as Therapeutic Targets in Breast Cancer

The Breast Cancer Research Foundation Inc.

2019 — 2020

2-Oxoglutarate Dependent Dioxygenases as Therapeutic Targets in Breast Cancer

The Breast Cancer Research Foundation Inc.

2014 — 2015

2-Oxoglutarate Dependent Dioxygenases as Therapeutic Targets in Breast Cancers

The Breast Cancer Research Foundation Inc.

2016 — 2017

Education

Duke University

Career Timeline

Harvard University?–present
Howard Hughes Medical Institute1998–present
Dana–Farber Cancer Institute2002–present

Positions & Roles

board of directors member

Data Sources

Profile data aggregated from Wikidata, ORCID, and curated award records. Citation metrics may vary between sources.